Health & Fitness
Health and Fitness
Health and Fitness 
Fri, January 30, 2009
Thu, January 29, 2009
XenoPort to Release Fourth Quarter Financial Results on February 12, 2009
SANTA CLARA, Calif.--([ BUSINESS WIRE ])--XenoPort, Inc. (Nasdaq: XNPT) announced today that it will release its fourth quarter and fiscal year end financial results on February 12, 2009 at approximately 4:30 p.m. Eastern Time. The company will host a conference call at 5:00 p.m. Eastern Time that same day. A replay of the call will be available for one week following the event.
To access the conference call via the Internet, go to [ www.XenoPort.com ]. Please join the call at least 15 minutes prior to the start to ensure time for any software downloads that may be required.
To access the live conference call via phone, dial 1-888-275-3514. International callers may access the live call by dialing 706-679-1417. The reference number to enter the call is 83488800.
The replay of the conference call may be accessed that same day after 8:00 p.m. Eastern Time, via the Internet, at [ www.XenoPort.com ], or via phone at 1-800-642-1687 for domestic callers, or 706-645-9291 for international callers. The reference number to enter the replay of the call is 83488800.
About XenoPort
XenoPort, Inc. is a biopharmaceutical company focused on developing a portfolio of internally discovered product candidates that utilize the body's natural nutrient transport mechanisms to improve the therapeutic benefits of existing drugs. XenoPort is developing its lead product candidate in partnership with Astellas Pharma Inc. and GlaxoSmithKline. XenoPort's product candidates are being studied for the potential treatment of restless legs syndrome, neuropathic pain, migraine headaches, gastroesophageal reflux disease, spasticity related to spinal cord injury, acute back spasms and Parkinson's disease.
To learn more about XenoPort, please visit the Web site at [ www.XenoPort.com ].
XenoPort is a registered trademark.
XNPT2F